Recruiting

Observational Study

Sponsor:

University of Manitoba

Code:

NCT01775956

Conditions

Septic Shock

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Study Details

Brief summary:

Septic shock remains the dominant cause of death in ICU's of the developed world with approximately 400,000 cases annually in the US and another 20,000 annually in Canada. While many retrospective and prospective reviews of septic shock patients have been undertaken worldwide, many key questions remain unanswered. These questions include the true incidence, associated morbidity and mortality of septic shock in North America, key factors associated with successful management and markers suggesting a high probability of a complicated clinical course. Part of the reason for the persistence of these questions, is the fact that previous and ongoing reviews of septic shock and severe sepsis have been either limited in number (typically <150) or biased by the need to be eligible for specific clinical trials (typically, non-eligible patients have not been followed and had data collected.

We propose to examine specific questions within a temporally comprehensive cohort of septic shock patients by review of individual charts using a defined data-extraction template.

Conditions

Septic Shock

Study ID

NCT01775956

Start date

Dec, 2003

Status verified date

Jul, 2013

Completion date

Jul, 2018

Anticipated

Primary completion date

Jan, 2018

Anticipated

Eligibility Criteria

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Inclusion criteria.

  • The primary analysis will include all patients admitted to the institution with a final diagnosis of septic shock (including transfers).

Exclusion criteria:

  • ICU patients who do not have a diagnosis of septic shock
  • These are the only Inclusion/Exclusion criteria.

Study Design

Enrollment

10000 participants

Anticipated

Interventions and Outcome Measures

Primary outcome measure

  • Outcome as determined by treatment choices [ Time Frame: Participants will be followed for the Average length of hospital stay 4-5 weeks ]

Central Contacts and Locations

Central contacts

Locations

Health Sciences Centre, Winnipeg

Recruiting

Winnipeg, Manitoba, Canada, R3A 1R9

Contacts

More Information

Sponsor

University of Manitoba

Last update posted

Jul 25, 2013

Last verified

Jul, 2013

Trial information was received from ClinicalTrials.gov and was last updated on 2026-09-10. This information was provided to ClinicalTrials.gov by University of Manitoba on 2013-07-25.